Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma

  • TERAMURA Yuki
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • KAMEDA Kazuaki
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • KANDA Junya
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • GOMYO Ayumi
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • HAYAKAWA Jin
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • AKAHOSHI Yu
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • KOMIYA Yusuke
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • HARADA Naonori
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • UGAI Tomotaka
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • ISHIHARA Yuko
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • KAWAMURA Koji
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • SAKAMOTO Kana
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • SATO Miki
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • WADA Hidenori
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • TERASAKO-SAITO Kiriko
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • KIMURA Shun-ichi
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • KIKUCHI Misato
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • NAKASONE Hideki
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • KAKO Shinichi
    Division of Hematology, Saitama Medical Center, Jichi Medical University
  • KANDA Yoshinobu
    Division of Hematology, Saitama Medical Center, Jichi Medical University Division of Hematology, Department of Medicine, Jichi Medical University

Bibliographic Information

Other Title
  • CD5陽性びまん性大細胞型B細胞リンパ腫治療中に発症し診断に苦慮した結核性髄膜炎
  • 症例報告 第3回日本血液学会関東甲信越地方会 優秀演題 CD5陽性びまん性大細胞型B細胞リンパ腫治療中に発症し診断に苦慮した結核性髄膜炎
  • ショウレイ ホウコク ダイ3カイ ニホン ケツエキ ガッカイ カントウ コウシンエツチホウカイ ユウシュウ エンダイ CD5 ヨウセイビマンセイ ダイ サイボウガタ B サイボウ リンパシュ チリョウ チュウ ニ ハッショウ シ シンダン ニ クリョ シタ ケッカクセイ ズイマクエン

Search this article

Abstract

The patient was a 62-year-old woman with CD5+ diffuse large B-cell lymphoma. Treatment with the R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) was started. On the eleventh day of the third cycle, headache and low grade fever developed. Her consciousness gradually deteriorated. Seven days after symptom onset, she was brought to the emergency department of our hospital. Cerebrospinal fluid (CSF) analysis revealed a white blood cell count of 25/μl, and a protein level of 188 mg/dl. Antibacterial and antiviral agents were administered based on a diagnosis of acute meningitis. She showed no improvement. We performed another lumbar puncture and intrathecal chemotherapy, a combination of methotrexate and dexamethasone, was administered because we suspected central nervous system involvement of lymphoma. She showed transient improvement. On day 12, we started the R-MPV regimen (rituximab, methotrexate, procarbazine, and vincristine). However, fever and disturbance of consciousness persisted. On day 20, we empirically started anti-tuberculosis treatment. Four days later, tubercle bacilli were confirmed by CSF culture after a 23-day incubation. We ultimately confirmed a diagnosis of tuberculous meningitis. Impaired cellular immunity in lymphoma patients increases the risk of tuberculosis. It is important to consider tuberculous meningitis in the differential diagnosis of a lymphoma patient presenting with meningitis.

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 57 (5), 597-601, 2016

    The Japanese Society of Hematology

Details 詳細情報について

Report a problem

Back to top